The regulation of sphingosine-1-phosphate 1 receptor signalling and trafficking in astrocytes : implications for Multiple Sclerosis
Citation:Luke M. Healy, 'The regulation of sphingosine-1-phosphate 1 receptor signalling and trafficking in astrocytes : implications for Multiple Sclerosis', [thesis], Trinity College (Dublin, Ireland). Department of Physiology, 2012, pp 181
Healy TCD THESIS 10054 The regulation.pdf (PDF) 102.2Mb
Multiple Sclerosis (MS) is a chronic, inflammatory and autoimmune disease of the central nervous system (CNS). Fingolimod (FTY720-P) is an immunomodulatory drug recently granted FDA approval for the treatment of remitting relapsing MS. This compound is a pro-drug and an analogue of sphingosine-1-phosphate (S1P), an important lipid mediator that is implicated in a wide range of biological processes. The clinical benefits of FTY720-P have been attributed to its modulation of a group of G- protein coupled receptors (GPCRs) which naturally bind S1P. Internalisation of these S1P receptors by binding of FTY720-P limits entry of autoreactive T-cells into brain tissue.
Author: Healy, Luke M.
Publisher:Trinity College (Dublin, Ireland). Department of Physiology
Note:TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: firstname.lastname@example.org
Type of material:thesis
Availability:Full text available